Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6000 participants
OBSERVATIONAL
2017-03-23
2037-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Italian Study of Patients With Lymphoma
NCT06814925
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
NCT06806488
Tumor Registry of Lymphatic Neoplasia
NCT00889798
Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
NCT06733987
Brazilian Prospective Hodgkin Lymphoma Registry
NCT02589548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hodgkin lymphoma
Patient registry
Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Non-Hodgkin lymphoma
Patient registry
Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Myeloma
Patient registry
Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient registry
Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
A.O. Ospedale Papa Giovanni XXIII
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rambaldi Alessandro
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandro Rambaldi, MD
Role: PRINCIPAL_INVESTIGATOR
A.O. Ospedale Papa Giovanni XXIII
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII
Bergamo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BLCR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.